The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | The role of transplant in CTCL
Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, gives an overview of the role of transplantation in the treatment of patients with cutaneous T-cell lymphoma (CTCL), talking on how it can prolong survival. Prof. Scarisbrick discusses the practicalities of transplantation in clinical practice, describing the use of reduced-intensity conditioning following the Stanford protocol, which combines total skin electron beam (TSEB), total nodal irradiation and ATG. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
